Plasticity of Cancer Cell Invasion-Mechanisms and Implications for Therapy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Advances in Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/bs.acr.2016.07.005PMID 27613134
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteolytic and non-proteolytic regulation of collective cell invasion: tuning by ECM density and organization

  2016cited by this paper
• RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition

  2016cited by this paper
• Plasticity of Cell Migration In Vivo and In Silico.

  2016cited by this paper
• The front and rear of collective cell migration

  2016cited by this paper
• Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters

  2016cited by this paper
• A small molecule inhibitor of tropomyosin dissociates actin binding from tropomyosin-directed regulation of actin dynamics

  2016cited by this paper
• Third harmonic generation microscopy of cells and tissue organization

  2016cited by this paper
• Dasatinib and docetaxel combination treatment for patients with castration-resistant progressive prostate cancer: A phase I/II study (CA180086).

  2016cited by this paper
• A collective route to metastasis: Seeding by tumor cell clusters

  2016cited by this paper
• Mechanisms of ephrin–Eph signalling in development, physiology and disease

  2016cited by this paper
• Nuclear envelope rupture and repair during cancer cell migration

  2016cited by this paper
• Metastatic colonization by circulating tumour cells

  2016cited by this paper
• Strain Stiffening of Fibrillar Collagen during Individual and Collective Cell Migration Identified by AFM Nanoindentation.

  2016cited by this paper
• Hypoxic control of metastasis

  2016cited by this paper
• Leader cells regulate collective cell migration via Rac activation in the downstream signaling of integrin β1 and PI3K

  2015cited by this paper
• Confinement and low adhesion induce fast amoeboid migration of slow mesenchymal cells.

  2015cited by this paper
• Control of cell-cell forces and collective cell dynamics by the intercellular adhesome

  2015cited by this paper
• Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer.

  2015cited by this paper
• SRC inhibition represents a potential therapeutic strategy in liposarcoma

  2015cited by this paper
• Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas

  2015cited by this paper
• Fibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin αvβ5-mediated adhesion

  2015cited by this paper
• β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer

  2015cited by this paper
• Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1

  2015cited by this paper
• HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation

  2015cited by this paper
• Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells

  2015cited by this paper
• The integrin expression profile modulates orientation and dynamics of force transmission at cell–matrix adhesions

  2015cited by this paper
• Targeting the TGFβ pathway for cancer therapy.

  2015cited by this paper
• Adipocyte activation of cancer stem cell signaling in breast cancer.

  2015cited by this paper
• Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis

  2015cited by this paper
• Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways.

  2015cited by this paper
• Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer

  2015cited by this paper
• Modes of cancer cell invasion and the role of the microenvironment.

  2015cited by this paper
• Collective cell migration: guidance principles and hierarchies.

  2015cited by this paper
• PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness

  2015cited by this paper
• Rho kinase inhibitors block melanoma cell migration and inhibit metastasis.

  2015cited by this paper
• Approaches of targeting Rho GTPases in cancer drug discovery

  2015cited by this paper
• Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?

  2015cited by this paper
• Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer.

  2015cited by this paper
• Brain tumour cells interconnect to a functional and resistant network

  2015cited by this paper
• A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors

  2015cited by this paper
• Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

  2014cited by this paper
• Rho GTPases

  2014cited by this paper
• Targeting Microtubules by Natural Agents for Cancer Therapy

  2014cited by this paper
• Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut

  2014cited by this paper
• Rho/ROCK signaling in motility and metastasis of gastric cancer.

  2014cited by this paper
• SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway.

  2014cited by this paper
• Molecular Pathways: Targeting the Kinase Effectors of RHO-Family GTPases

  2014cited by this paper
• Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer

  2014cited by this paper
• A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma

  2014cited by this paper
• FAK Inhibition Abrogates the Malignant Phenotype in Aggressive Pediatric Renal Tumors

  2014cited by this paper
• Cell jamming: collective invasion of mesenchymal tumor cells imposed by tissue confinement.

  2014cited by this paper
• SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6.

  2014cited by this paper
• Molecular mechanisms of epithelial–mesenchymal transition

  2014cited by this paper
• FAK in cancer: mechanistic findings and clinical applications

  2014cited by this paper
• Assembly, heterogeneity, and breaching of the basement membranes

  2014cited by this paper
• Both contractile axial and lateral traction force dynamics drive amoeboid cell motility

  2014cited by this paper
• Lymphocytes from chronic lymphocytic leukaemia undergo ABL1-linked amoeboid motility and homotypic interaction as an early adaptive change to ex vivo culture

  2014cited by this paper
• In vivo Magnetic Resonance Imaging of Tumor Protease Activity

  2014cited by this paper
• Interplay of RhoA and mechanical forces in collective cell migration driven by leader cells

  2014cited by this paper
• Fibronectin promotes migration and invasion of ovarian cancer cells through up‐regulation of FAK–PI3K/Akt pathway

  2014cited by this paper
• The Inhibition of Src Family Kinase Suppresses Pancreatic Cancer Cell Proliferation, Migration, and Invasion

  2014cited by this paper
• Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma

  2014cited by this paper
• Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function

  2014cited by this paper
• FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth

  2014cited by this paper
• Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.

  2014cited by this paper
• Role of hypoxia in epithelial-to-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)

  2014cited by this paper
• Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas

  2014cited by this paper
• Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles

  2014cited by this paper
• Pharmacological inhibition of actin assembly to target tumor cell motility.

  2014cited by this paper
• Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

  2014cited by this paper
• Illuminating breast cancer invasion: diverse roles for cell-cell interactions.

  2014cited by this paper
• Cancer cell invasion and EMT marker expression: a three‐dimensional study of the human cancer–host interface

  2014cited by this paper
• Hypoxia and the extracellular matrix: drivers of tumour metastasis

  2014cited by this paper
• Adherens junction treadmilling during collective migration

  2014cited by this paper
• Chronic Inflammation and Cytokines in the Tumor Microenvironment

  2014cited by this paper
• Epithelial–Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression

  2014cited by this paper
• Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells

  2014cited by this paper
• Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor.

  2014cited by this paper
• A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer

  2014cited by this paper
• Exploiting the Inherent Metastasis of Leukemia to Improve Chemotherapeutic Approaches

  2014cited by this paper
• Overexpression of c-Met increases the tumor invasion of human prostate LNCaP cancer cells in vitro and in vivo

  2014cited by this paper
• Dynamic functions of RhoA in tumor cell migration and invasion

  2013cited by this paper
• Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer

  2013cited by this paper
• Preclinical intravital microscopy of the tumour-stroma interface: invasion, metastasis, and therapy response.

  2013cited by this paper
• Arp2/3 complex inhibitors adversely affect actin cytoskeleton remodeling in the cultured murine kidney collecting duct M-1 cells

  2013cited by this paper
• Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

  2013cited by this paper
• Mechanotransduction of mesenchymal melanoma cell invasion into 3D collagen lattices: filopod-mediated extension-relaxation cycles and force anisotropy.

  2013cited by this paper
• VEGF targets the tumour cell

  2013cited by this paper
• Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.

  2013cited by this paper
• Directional tissue migration through a self-generated chemokine gradient

  2013cited by this paper
• Tumor metastasis: moving new biological insights into the clinic

  2013cited by this paper
• TGF-&bgr; signaling and epithelial–mesenchymal transition in cancer progression

  2013cited by this paper
• The role and regulation of blebs in cell migration

  2013cited by this paper
• Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma

  2013cited by this paper
• SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases.

  2013cited by this paper
• Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial.

  2013cited by this paper
• Collective invasion in breast cancer requires a conserved basal epithelial program.

  2013cited by this paper
• Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force

  2013cited by this paper
• Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β

  2013cited by this paper
• Cancer drug resistance: an evolving paradigm

  2013cited by this paper

• Cancer invasion plasticity during the metastatic cascade: strategies to survive and thrive.

  2026cites this paper
• Circulating tumor cells in lung cancer: Integrating stemness and heterogeneity to improve clinical utility.

  2025cites this paper
• CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting

  2025cites this paper
• Statistical and mechanical analysis of multi-pseudopodial locomotion in a testate amoeba, Arcella sp.

  2025cites this paper
• Prognostic Significance of Tumour Budding and Tumour-infiltrating Lymphocytes in Gallbladder Carcinoma

  2025cites this paper
• Subpopulation commensalism promotes Rac1-dependent invasion of single cells via laminin-332

  2024cites this paper
• Blebology: principles of bleb-based migration.

  2024cites this paper
• N-cadherin dynamically regulates pediatric glioma cell migration in complex environments

  2024cites this paper
• TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma

  2024cites this paper
• N-cadherin dynamically regulates pediatric glioma cell migration in complex environments

  2024cites this paper
• Microtubule‐associated NAV3 regulates invasive phenotypes in glioblastoma cells

  2024cites this paper
• MEK inhibitors and DA‐Raf, a dominant‐negative antagonist of the Ras–ERK pathway, prevent the migration and invasion of KRAS‐mutant cancer cells

  2024cites this paper
• Educate, not kill: treating cancer without triggering its defenses.

  2024cites this paper
• The emerging role of microtubules in invasion plasticity

  2023cites this paper
• Solanum nigrum Linn.: Advances in anti-cancer activity and mechanism in digestive system tumors

  2023influential citation
• The role of tumor microenvironment on cancer stem cell fate in solid tumors

  2023cites this paper
• Development of a Synthetic, Injectable Hydrogel to Capture Residual Glioblastoma and Glioblastoma Stem‐Like Cells with CXCL12‐Mediated Chemotaxis

  2023cites this paper
• In colon cancer cells fascin1 regulates adherens junction remodeling

  2023influential citation
• Circulating tumor cells in neuroblastoma: Current status and future perspectives

  2022cites this paper
• LIMCH1 as a New Potential Metastasis Predictor in Breast Cancer

  2022cites this paper
• Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Bushen Hugu Decoction in the Treatment of Malignant Tumor Bone Metastases

  2022cites this paper
• Plasticity of cancer invasion and energy metabolism.

  2022cites this paper
• Hematogenous metastasis and tumor dormancy as concepts or dogma? The continuum of vessel co-option and angiotropic extravascular migratory metastasis as an alternative

  2022cites this paper
• Invasion-Associated Reorganization of Laminin 332 in Oral Squamous Cell Carcinomas: The Role of the Laminin γ2 Chain in Tumor Biology, Diagnosis, and Therapy

  2022cites this paper
• How does plasticity of migration help tumor cells to avoid treatment: Cytoskeletal regulators and potential markers

  2022cites this paper
• High Throughput 3D Cell Migration Assay Using Micropillar/Microwell Chips

  2022cites this paper
• Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapy

  2022cites this paper
• Changes in endocan and dermatan sulfate are associated with biomechanical properties of abdominal aortic wall during aneurysm expansion and rupture.

  2022cites this paper
• Physics of liquid crystals in cell biology.

  2021cites this paper
• Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system

  2021cites this paper
• Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer

  2021cites this paper
• The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers

  2021influential citation
• Phenotypic Plasticity of Cancer Cells Based on Remodeling of the Actin Cytoskeleton and Adhesive Structures

  2021cites this paper
• Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion

  2021cites this paper
• Light and electron microscopy continuum-resolution imaging of 3D cell cultures

  2021cites this paper
• Context-Dependent Roles of Claudins in Tumorigenesis

  2021cites this paper
• A Drosophila RNAi screen reveals conserved glioblastoma-related adhesion genes that regulate collective cell migration

  2021cites this paper
• Crosstalks Among Cancer Stem Cells and Histopathologic Features in Determining Prognosis in Canine Mammary Gland Carcinomas

  2021cites this paper
• Increased Level of Long Non-Coding RNA MALAT1 Is a Common Feature of Amoeboid Invasion

  2020cites this paper
• Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity.

  2020cites this paper
• Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway

  2020cites this paper
• Actin cytoskeleton in mesenchymal-to-amoeboid transition of cancer cells.

  2020cites this paper
• Paxillin family of focal adhesion adaptor proteins and regulation of cancer cell invasion.

  2020cites this paper
• СРАВНИТЕЛЬНЫЙ АНАЛИЗ МИГРАЦИОННОЙ АКТИВНОСТИ И ИНВАЗИВНОГО ПОТЕНЦИАЛА КУЛЬТИВИРУЕМЫХ КЛЕТОК СОЛИДНЫХ ОПУХОЛЕЙ ЧЕЛОВЕКА

  2020cites this paper
• Plasticity of cancer cell invasion: Patterns and mechanisms

  2020cites this paper
• Sustained Inflammatory Signalling through Stat1/Stat2/IRF9 Is Associated with Amoeboid Phenotype of Melanoma Cells

  2020cites this paper
• Using migrating cells as probes to illuminate features in live embryonic tissues

  2020cites this paper
• Development of a Prognostic Model for Colorectal Cancer Based on Four EMT-related Genes

  2020cites this paper
• COMPARATIVE ANALYSIS OF MIGRATION ACTIVITY AND INVASIVE POTENTIAL OF CULTURED SOLID TUMOR CELLS

  2020cites this paper
• 4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis

  2020cites this paper
• Microtubule-targeting agents and their impact on cancer treatment.

  2020cites this paper
• Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells

  2019cites this paper
• The Evolution of Placental Invasion and Cancer Metastasis are Causally Linked

  2019cites this paper
• Adaptive F-Actin Polymerization and Localized ATP Production Drive Basement Membrane Invasion in the Absence of MMPs.

  2019cites this paper
• P120-catenin dependent collective brain infiltration by glioma cell networks

  2019cites this paper
• The CTLH Complex in Cancer Cell Plasticity

  2019cites this paper
• Ping-Pong—Tumor and Host in Pancreatic Cancer Progression

  2019cites this paper
• Integrin β4 promotes invasion and anoikis resistance of papillary thyroid carcinoma and is consistently overexpressed in lymphovascular tumor thrombus

  2019cites this paper
• Systems Biology of Cancer Metastasis.

  2019cites this paper
• Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells

  2019cites this paper
• Patient Trust and Participation in Cell Biological Research.

  2019cites this paper
• The extracellular matrix in tumor progression and metastasis

  2019cites this paper
• Microenvironment Influences Cancer Cell Mechanics from Tumor Growth to Metastasis.

  2018cites this paper
• Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells

  2018cites this paper
• Every step of the way: integrins in cancer progression and metastasis

  2018cites this paper
• Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis

  2018cites this paper
• A 3D Topographical Model of Parenchymal Infiltration and Perivascular Invasion in Glioblastoma

  2018cites this paper
• A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.

  2018cites this paper
• Enhanced blebbing as a marker for metastatic prostate cancer.

  2018cites this paper
• Invasiveness of Cells Leads to Changes in Their Interaction Behavior with the Glycocalyx

  2018cites this paper
• Circulating tumor cells and the metastatic process: the complexity of malignancy

  2018influential citation
• Targeting invasive properties of melanoma cells

  2017cites this paper
• Invading, Leading and Navigating Cells in Caenorhabditis elegans: Insights into Cell Movement in Vivo

  2017cites this paper
• Tuning Collective Cell Migration by Cell-Cell Junction Regulation.

  2017cites this paper
• Proteomic Analysis of Neuroblastoma‐Derived Exosomes: New Insights into a Metastatic Signature

  2017cites this paper
• A biosystems approach to identify the molecular signaling mechanisms of TMEM30A during tumor migration

  2017cites this paper
• HYPOXIA-INDUCED AMOEBOID CANCER CELL MIGRATION: PRINCIPLES, MOLECULAR MECHANISMS AND PLASTICITY

  2017cites this paper